Crystal structures of zidovudine- or lamivudine-resistant human immunodeficiency virus type 1 reverse transcriptases containing mutations at codons 41, 184, and 215

被引：52
|
作者：
Chamberlain, PP
Ren, J
Nichols, CE
Douglas, L
Lennerstrand, J
Larder, BA
Stuart, DI
Stammers, DK
机构：
[1] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England
[2] Oxford Ctr Mol Sci, Oxford OX1 3QT, England
[3] Visible Genet, Cambridge CB4 0GA, England
来源：
JOURNAL OF VIROLOGY | 2002年 / 76卷 / 19期
关键词：
D O I：
10.1128/JVI.76.19.10015-10019.2002
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Six structures of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) containing combinations of resistance mutations for zidovudine (AZT) (M41L and T215Y) or lamivudine (M184V) have been determined as inhibitor complexes. Minimal conformational changes in the polymerase or nonnucleoside RT inhibitor sites compared to the mutant RTMC (D67N, K70P, T215F, and K219N) are observed, indicating that such changes may occur only with certain combinations of mutations. Model building M41L and T215Y into HIV-1 RT-DNA and docking in ATP that is utilized in the pyrophosphorolysis reaction for AZT resistance indicates that some conformational rearrangement appears necessary in RT for ATP to interact simultaneously with the M41L and T215Y mutations.
引用
收藏
页码：10015 / 10019
页数：5
相关论文
共 50 条
  • [1] Lamivudine-resistant human immunodeficiency virus type 1 variants (184V) require multiple amino acid changes to become co-resistant to zidovudine in vivo
    Nijhuis, M
    Schuurman, R
    deJong, D
    vanLeeuwen, R
    Lange, J
    Danner, S
    Keulen, W
    deGroot, T
    Boucher, CAB
    JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (02): : 398 - 405
  • [2] Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215
    Goudsmit, J
    DeRonde, A
    DeRooij, E
    DeBoer, R
    JOURNAL OF VIROLOGY, 1997, 71 (06) : 4479 - 4484
  • [3] Deoxynucleoside triphosphate concentrations emphasize the processivity defect of lamivudine-resistant variants of human immunodeficiency virus type 1 reverse transcriptase
    Back, NKT
    Berkhout, B
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) : 2484 - 2491
  • [4] Stampidine is a potent inhibitor of zidovudine- and nucleoside analog reverse transcriptase inhibitor-resistant primary clinical human immunodeficiency virus type 1 isolates with thymidine analog mutations
    Uckun, FM
    Pendergrass, S
    Venkatachalam, TK
    Qazi, S
    Richman, D
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) : 3613 - 3616
  • [5] THE EFFECTS OF CYSTEINE MUTATIONS ON THE REVERSE TRANSCRIPTASES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2
    HIZI, A
    SHAHARABANY, M
    TAL, R
    HUGHES, SH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (02) : 1293 - 1297
  • [6] Pressure of zidovudine accelerates the reversion of lamivudine resistance-conferring M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1
    Diallo, K
    Oliveira, M
    Moisi, D
    Brenner, B
    Wainberg, MA
    Götte, M
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (07) : 2254 - 2256
  • [7] KINETICS OF DIFFERENT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE TRANSCRIPTASES RESISTANT TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-SPECIFIC REVERSE-TRANSCRIPTASE INHIBITORS
    DEBYSER, Z
    DEVREESE, K
    KNOPSGERRITS, PP
    BAEKELANDT, V
    BHIKHABHAI, R
    STRANDBERG, B
    PAUWELS, R
    ANNE, J
    DESMYTER, J
    DE CLERCQ, E
    MOLECULAR PHARMACOLOGY, 1993, 43 (04) : 521 - 526
  • [8] Coresistance to zidovudine and foscarnet is associated with multiple mutations in the human immunodeficiency virus type 1 reverse transcriptase
    Tachedjian, G
    French, M
    Mills, J
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (11) : 3038 - 3043
  • [9] Inhibition of purified recombinant reverse transcriptase from wild-type and zidovudine-resistant clinical isolates of human immunodeficiency virus type 1 by zidovudine, stavudine, and lamivudine triphosphates
    Duan, CY
    Poticha, D
    Stoeckli, TC
    Petropoulos, CJ
    Whitcomb, JM
    McHenry, CS
    Kuritzkes, DR
    JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (10): : 1336 - 1340
  • [10] Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants
    Yerly, S
    Rakik, A
    De Loes, SK
    Hirschel, B
    Descamps, D
    Brun-Vézinet, F
    Perrin, L
    JOURNAL OF VIROLOGY, 1998, 72 (05) : 3520 - 3523
12345